Each cell vial contains a 2-4% suspension of pooled C-E-D red cells suspended in a buffered preservative solution containing adenosine and adenine.

共有 1 個藥物證書使用此成份

申請商
永弘科技有限公司 
適應症
含量
發證日期
2005-11-27